索拉菲尼布会改变瘤微环境中的间歇质子和水平:A1H/23Na光谱成像研究
Muhammad H Khan1, John J Walsh1, Sara Kurdi1
1Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA.
NMR in biomedicine
|January 7, 2025
概括
针对离子平衡的癌症疗法可以使用磁共振成像早期追踪. 测量间位酸度和度可以在瘤生长发生变化之前显示治疗的有效性,这有助于对质母细胞瘤治疗的监测.
科学领域:
- 在瘤学瘤学.
- 生物物理学的生物物理.
- 医疗成像医学成像
背景情况:
- 细胞代谢,特别是有氧糖解,在瘤中通过细胞膜显著影响离子度 (H+,Na+,K+).
- 功能障碍的Na+-K+ ATPase活性和改变的离子交换器/输送器有助于癌症中异常的细胞内和细胞间离子水平.
- Na+和H+离子的不平衡与关键的癌症特征有关,包括入侵,增殖,血管生成和免疫逃避.
研究的目的:
- 研究使用磁共振光谱成像 (MRSI) 绘制间歇性pH (pHo) 和Na+ (Nao+) 地图的潜力,以评估质母细胞瘤治疗反应.
- 评估索拉费尼布治疗如何影响体内U87质母细胞瘤模型中的间歇离子度和pH值.
- 确定间歇性离子微环境的变化是否先于瘤生长的可观测变化.
主要方法:
- 质子 (1H) 和 (23Na) 的MRSI被用来非侵入性地绘制U87质母细胞瘤异体移植中的间歇性pH和Na+水平.
- 该研究比较了用sorafenib (一种蛋白激酶抑制剂) 治疗的瘤中的离子变化与安慰剂对照.
- 对瘤生长进行了监测,以将离子微环境的变化与治疗疗效相关联.
主要成果:
- 与安慰剂相比,索拉芬尼治疗减缓了瘤生长,并使跨膜H+和Na+水平正常化.
- 安慰剂瘤呈现出酸性和不太的间隙空间,这是一个增殖状态的特征.
- 索拉芬尼治疗的瘤显示出较少的酸性和盐度较高的间歇空间,类似于正常组织,这些离子变化之前的生长抑制.
结论:
- 间歇性离子微环境变化,特别是pHo和Nao+,可以作为质母细胞瘤治疗反应的早期生物标志物.
- 结合1H和23Na的MRSI提供了一个强大的工具来监测调节离子运输机制的疗法的有效性.
- 这些发现表明,一种新的成像方法可以实时跟踪治疗疗效,并可能指导质母细胞瘤的治疗决策.
更多相关视频
10:46In Vivo EPR Assessment of pH, pO2, Redox Status, and Concentrations of Phosphate and Glutathione in the Tumor Microenvironment
Published on: March 16, 2018
8.2K
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.2K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:15Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
02:17The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
01:11Renal Failure: Dose Adjustments
34
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
34